Company Profile for Eyenuk, Inc.

--()--Eyenuk, Inc., headquartered in Los Angeles, California, is an AI diagnostic company focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and chronic diseases at the point of care. Using computer vision and machine learning expertise, the company is developing a portfolio of products based on its proprietary retinal image analysis technology combined with deep learning to identify and track the progression of diseases including diabetic retinopathy, glaucoma, age-related macular degeneration, risk of stroke, cardiovascular risk, and Alzheimer’s disease. EyeArt™ development was partially supported by prestigious National Eye Institute (NEI/NIH) grants (EB013585, EY026864, EY027241). EyeArt™ has received CE Marking and Health Canada approval, and is commercially available in the European Union and in Canada. In the United States, EyeArt™ is limited by federal law to investigational use only and is not available for sale. For more information, visit

Company: Eyenuk, Inc.
Headquarters Address: 5850 Canoga Ave., Suite 250
Los Angeles, CA 91367
Main Telephone:



Type of Organization: Private
Industry: Medical Devices
Key Executives: VP, Global BD, Corporate Alliances: Kevin Skol
CEO: Kaushal Solanki
Head of Development: Greg Russell
Investor Relations
Contact: Kevin Skol




Social Media Profiles